statistiche ricercatore

Nome	#
First-line disease-modifying drugs in relapsingâremitting multiple sclerosis: an Italian real-life multicenter study on persistence	57
Correlation between cortical lesions and cognitive impairment in multiple sclerosis	57
Neuromyelitis Optica Spectrum Disorder Attack Triggered by Herpes Zoster Infection	48
Location of first attack predicts the site of subsequent relapses in multiple sclerosis	44
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis	43
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	40
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study	37
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis	37
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?	34
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey	31
Successful intravenous immunoglobulin treatment in relapsing MOG-antibody-associated disease	30
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience	26
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders	22
Totale	506

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	101	5	1	0	2	3	11	14	2	4	17	23	19
2020/2021	43	1	4	4	3	6	3	1	3	8	6	4	0
2021/2022	63	0	5	0	3	5	1	8	5	0	3	4	29
2022/2023	201	22	17	24	7	5	19	0	12	86	1	8	0
2023/2024	80	3	18	4	3	5	16	1	2	4	7	6	11
2024/2025	2	2	0	0	0	0	0	0	0	0	0	0	0
Totale													506